Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Saga Communications A | SGA | 15. nov 2024 | 11.90 | -0.50 |
Sage Therapeutics | SAGE | 15. nov 2024 | 5.10 | -5.03 |
Sagimet Biosciences | SGMT | 15. nov 2024 | 4.73 | -8.69 |
SAI.TECH Global | SAI | 15. nov 2024 | 0.75 | 0.00 |
Saia | SAIA | 15. nov 2024 | 522.37 | -3.68 |
SAIHEAT A | SAIH | 15. nov 2024 | 0.91 | 0.00 |
Salarius Pharmaceuticals | SLRX | 15. nov 2024 | 1.34 | -2.90 |
Salesforce | CRM | 15. nov 2024 | 325.26 | -1.93 |
Sally Beauty | SBH | 15. nov 2024 | 13.41 | -2.69 |
Samfine Creation Group | SFHG | 15. nov 2024 | 15.00 | 0.00 |
Samsara A | IOT | 15. nov 2024 | 49.51 | -2.75 |
San Juan Basin Royalty Trust Unit | SJT | 15. nov 2024 | 3.89 | -2.75 |
Sana Biotechnology | SANA | 15. nov 2024 | 2.42 | -6.56 |
Sanara MedTech | SMTI | 15. nov 2024 | 34.65 | -3.75 |
SandRidge Energy | SD | 15. nov 2024 | 11.45 | -2.55 |
Sandstorm Gold | SAND | 15. nov 2024 | 5.36 | -2.37 |
Sandy Spring Bancorp | SASR | 15. nov 2024 | 37.63 | -1.00 |
Sangamo Therapeutics | SGMO | 15. nov 2024 | 2.05 | -4.65 |
Sangoma Technologies | SANG | 15. nov 2024 | 6.25 | -1.57 |
Sanmina | SANM | 15. nov 2024 | 76.96 | -0.89 |
Sanofi ADR | SNY | 15. nov 2024 | 47.97 | +0.31 |
Santech ADR | STEC | 15. nov 2024 | 1.12 | -2.61 |
SAP ADR | SAP | 15. nov 2024 | 228.31 | -1.34 |
Sapiens | SPNS | 15. nov 2024 | 28.00 | -1.96 |
Saratoga Investment New | SAR | 15. nov 2024 | 25.26 | +0.84 |
Sarepta Therapeutics | SRPT | 15. nov 2024 | 104.54 | -4.19 |
Sasol ADR | SSL | 15. nov 2024 | 5.24 | +1.16 |
Satellogic A | SATL | 15. nov 2024 | 0.99 | -2.00 |
SatixFy Communications | SATX | 15. nov 2024 | 0.78 | -5.93 |
Saul Centers | BFS | 15. nov 2024 | 39.43 | -0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.